1 Min Read
April 27 (Reuters) - Vistagen Therapeutics Inc
* Vistagen therapeutics inc - announces peer-reviewed publication in journal of pain highlighting av-101’s potential for treating neuropathic pain Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.